Angelini said to be explore acquisition of Catalyst Pharma (CPRX)

Angelini exploring the acquisition of Catalyst Pharma indicates potential strategic consolidation in the biotech sector.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Pakistan's representative to the United Nations: We are continuing our diplomatic efforts to resolve the crisis between the United States and Iran, via Al Araby

US Secretary of State Rubio says he thinks the Iranians are serious in their attempts to get out of their predicament; their country has suffered many problems.

Angelini said to be explore acquisition of Catalyst Pharma (CPRX)

Google (GOOGL) staff have written a letter to CEO Pichai to refuse him from letting the US government use its AI tech for classified military operations, via FT

Newsquawk Daily US Earnings Estimates - 28th April 2026: KO, GLW, SPGI, TMUS, BKNG, SBUX, STX, V, WELL, SPOT

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

If the deal is accretive and seen as a positive move for Angelini, it could spur similar M&A activity among peers or impact investor sentiment in the sector. Keep an eye on how market participants react, especially regarding pricing multiples and the regulatory landscape.

Related headlines

The whole workspace, free to try.

Try it free